BioTech in Asia Analytics Dashboard
The BioTechAsia Analytics Dashboard provides an interactive visualization of the biotech industry in Asia with multiple key metrics and insights. The BioTech Companies Geomap shows the geographical distribution of biotech companies across Asia, with red dots indicating major company locations. The History of BioTech in Asia visualizes a timeline of biotech development and highlights major conferences, expos, and events in the sector.The SWOT Radar of Industry compares the performance of regions like East Asia, Southeast Asia, South Asia, and Western Asia based on factors such as talent, R&D development, and intellectual property.
55
Companies
10
Investors
70
AI Companies
160,230
Indicators
Top 8 Biggest BioTech Companies in Asia
Summary:
-
Chugai Pharmaceutical leads with a revenue of $55 billion, followed closely by Daiichi Sankyō at $52 billion.
-
Takeda Pharmaceutical ranks third with $44 billion, and Jiangsu Hengrui Medicine follows with $42 billion.
-
WuXi AppTec and Sun Pharmaceutical are positioned in the middle with revenues of $35 billion and $34 billion, respectively.
SWOT Radar of Industry
Summary:
-
East Asia (pink) leads across most categories, particularly in Patents and R&D Development, showcasing its dominance in innovation and research.
-
Southeast Asia (red) performs moderately well, particularly in Talent and Expertise and Collaboration Between Academia and Industry.
-
South Asia (yellow) shows moderate strength in R&D Development and Patents but lags in other areas such as Talent and Expertise and Intellectual Property Protection (IPP).